Essential Innovation and Access

September 2012 – A broad coalition of health NGOs, including HAI Europe, support a global health R&D convention and call for leadership of the EU in global health. Read their Position Paper.

5 June 2012 – At this year’s World Health Assembly (WHA) HAI followed what was arguably the most controversial issue up for discussion: The debates and action around agenda item 13.14: Consultative Expert Working Group on Research and Development: Financing and Coordination. Read the full Event Memo here.

April 2012 – HAI and the Alianza LAC-Global support the WHO’s Consultative Expert Working Group’s (CEWG) recommendation that negotiations begin on a binding biomedical R&D convention. Read the HAI/Alianza Policy Brief (EN): here and in Spanish (ES): here.

Nov 2011 – HAI Europe and Trans Atlantic Consumer Dialogue (TACD) organized an expert conference to examine how the EU Commission’s Research and Innovation Framework programme – Horizon 2020, will invest in economically and socially sustainable innovation models. Read more.

Jul 2011 – HAI Europe welcomes the Gilead licensing agreement with the Medicines Patent Pool. On 12 July 2011 the Medicines Patent Pool announced its first licences to increase access to HIV and Hepatitis B treatment in developing countries. Read more.